Production (Stage)
Lipocine Inc.
LPCN
$3.17
$0.0481.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.67M | 11.20M | 7.92M | 4.80M | 4.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.67M | 11.20M | 7.92M | 4.80M | 4.71M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.67M | 11.20M | 7.92M | 4.80M | 4.71M |
| SG&A Expenses | 4.55M | 5.00M | 5.26M | 5.26M | 5.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.14M | 12.35M | 13.22M | 14.51M | 15.08M |
| Operating Income | -6.47M | -1.16M | -5.29M | -9.71M | -10.37M |
| Income Before Tax | -5.37M | 9.00K | -4.05M | -8.49M | -8.97M |
| Income Tax Expenses | 700.00 | 700.00 | 1.30K | 1.30K | 800.00 |
| Earnings from Continuing Operations | -5.37 | 0.01 | -4.06 | -8.49 | -8.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.37M | 8.40K | -4.06M | -8.49M | -8.97M |
| EBIT | -6.47M | -1.16M | -5.29M | -9.71M | -10.37M |
| EBITDA | -6.42M | -1.11M | -5.26M | -9.67M | -10.34M |
| EPS Basic | -1.00 | 0.01 | -0.76 | -1.60 | -1.70 |
| Normalized Basic EPS | -0.63 | 0.00 | -0.47 | -1.00 | -1.06 |
| EPS Diluted | -1.05 | -0.04 | -0.79 | -1.62 | -1.72 |
| Normalized Diluted EPS | -0.64 | -0.01 | -0.48 | -1.00 | -1.07 |
| Average Basic Shares Outstanding | 21.39M | 21.36M | 21.32M | 21.27M | 21.16M |
| Average Diluted Shares Outstanding | 21.72M | 21.73M | 21.37M | 21.31M | 21.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |